Results 161 to 170 of about 53,405 (189)

Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer.

International Journal of Biological Macromolecules, 2015
L. Negi, M. Jaggi, Vidushi Joshi, Kar Ronodip, S. Talegaonkar   +4 more
semanticscholar   +1 more source

Imatinib mesylate-sensitive blast crisis immediately after discontinuation of imatinib mesylate therapy in chronic myelogenous leukemia: Report of two cases

American Journal of Hematology, 2004
Junichi Tsukada
exaly  

A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients

Cancer Chemotherapy and Pharmacology, 2015
J. Francis, B. Dubashi, R. Sundaram, S. Pradhan, A. Chandrasekaran   +4 more
semanticscholar   +1 more source

Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases

Annals of Medicine, 2003
Kari Eklund
exaly  

Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.

Journal of Pharmaceutical and Biomedical Analysis, 2015
Esen Bellur Atici, B. Karlığa
semanticscholar   +1 more source

Dysregulation of bone remodeling by imatinib mesylate

Blood, 2010
Timothy Hughes, Kate Vandyke, Andrew Zannettino   +2 more
exaly  

Imatinib Mesylate

2011
openaire   +2 more sources

Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma

Annals of Oncology, 2013
Marta Giorgia Podda, Alberto Garaventa, Roberto Luksch   +2 more
exaly  

Imatinib mesylate causes hypopigmentation in the skin

Cancer, 2003
Anne Tsao, Moshe Talpaz
exaly  

Imatinib Mesylate

2006
openaire   +1 more source